Addition of DNA dependent protein kinase (DNA-PK) inhibitor peposertib enhances efficacy of 177Lu-based radioimmunotherapy in pre-clinical models of prostate and renal cell carcinoma

被引：0

作者：

Johnstone, Cameron ^{[1
,2
]}

McDonald, Alexander ^{[1
,2
]}

Rigopoulos, Angela ^{[1
,2
]}

Burvenich, Ingrid ^{[1
]}

Wichmann, Christian ^{[1
]}

Wheatcroft, Michael ^{[3
]}

Yan, Edwin ^{[3
]}

Zimmermann, Astrid ^{[4
]}

Zeneke, Frank ^{[5
]}

Sirrenberg, Christian ^{[4
]}

Osellame, Laura ^{[1
]}

Cao, Zhipeng ^{[1
,2
]}

Scott, Fiona ^{[1
]}

Scott, Andrew ^{[1
,2
]}

机构：

[1] Olivia Newton John Canc Res Inst, Heidelberg, Australia

[2] La Trobe Univ, Melbourne, Vic, Australia

[3] Telix Pharmaceut, Melbourne, Vic, Australia

[4] Healthcare business Merck KGaA, Darmstadt, Germany

[5] EMD Serono, Billerica, MA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

P1271

引用

页数：3